Painful Truth: The Successful Failure Of A Biotech Startup

A investor ' s eulogy for Quartet Medicine: founded back in 2013, this biotech aspired to address neuropathic and inflammatory pain via a novel biologic mechanism. Unfortunately, after 3 years of solid drug discovery, the startup is being shut down due to an unexpected safety signal. R.I.P. Quartet
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news